Latest Actinic keratosis Stories
FLORHAM PARK, N.J., May 19, 2011 /PRNewswire/ -- PharmaDerm, a division of Nycomed US Inc., announced today that is has launched AK Connect, a patient resource program that contains information tailored to different types of patients about diagnosis, symptoms, treatment and support for actinic keratosis (AK).
New research from North Carolina State University shows that a â€œgatekeeperâ€ protein plays an important role in skin-cancer prevention in humans and lab mice.
HAYWARD, Calif., May 18, 2011 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and non-invasive skin tightening and a global market leader in aesthetic skin treatments, recently launched the "Take a Swing at the Sun" Facebook contest.
HAYWARD, Calif., April 12, 2011 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and non-invasive skin tightening, is pleased to serve as a returning sponsor of the Fresh Express Classic(TM) at TPC Stonebrae.
New research shows the NSAID Celebrex may help prevent some non-melanoma skin cancers from developing in patients who have pre-cancerous actinic keratoses lesions and are at high risk for having the disease.
WILMINGTON, Mass., Nov.
WILMINGTON, Mass., Nov. 2, 2010 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc. (Nasdaq: DUSA) announces that its third quarter corporate highlights and financial results press release will be issued on Friday, November 5th at 6:30 a.m. to be followed by a conference call at 8:30 a.m.
WILMINGTON, Mass., Oct. 26 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.Â® (Nasdaq: DUSA), a specialty pharmaceutical company focused on dermatology announced today that it has been named to Deloitte's 2010 Technology Fast 500 list.
HAYWARD, Calif., Sept. 16 /PRNewswire/ -- Solta Medical, Inc.
WILMINGTON, Mass., Sept.
- A trick or prank.